title: Synergistic antibacterial effects of copper and hexetidine against Streptococcus sobrinus and Streptococcus sanguis.
abstract: The aim of this study was to determine whether a combination of copper and hexetidine had a synergistic antibacterial effect against Streptococcus sobrinus OMZ 176 and S. sanguis 10556. Concentration ranges of the test agents alone and in combination were prepared by serial dilutions in microtiter trays with brain-heart infusion (BHI) broth as the bacterial growth medium. After incubation at 37 degrees C for 24 h, the minimum inhibitory concentration (MIC), corresponding to the lowest concentration showing no visible growth, was determined. Evaluated by the fractional inhibitory concentration index, a strong synergistic effect ranging from 0.39 to 0.40 was observed. A similar effect was also demonstrated by growth curves, which were constructed on the basis of growth in BHI broth with addition of MIC/4 of each agent alone or MIC/8 of each agent in combination. A probable explanation for these findings is that the surface-active hexetidine molecule alters the bacterial cell surfaces and thereby enables an increased amount of copper to be transported into the cell.
authors.affiliation: Department of Microbiology, Dental Faculty, University of Oslo, Norway.
authors.forename: J
authors.initials: J
authors.lastname: Grytten
authors.forename: A A
authors.initials: AA
authors.lastname: Scheie
authors.forename: E
authors.initials: E
authors.lastname: Giertsen
mesh_terms: D003300:Copper / Q000008:administration & dosage / Q000494:pharmacology*; D004338:Drug Combinations; D004357:Drug Synergism; D006590:Hexetidine / Q000008:administration & dosage / Q000494:pharmacology*; D013291:Streptococcus / Q000187:drug effects*; D013298:Streptococcus sanguis / Q000187:drug effects*
chemical_list: D004338:Drug Combinations; D003300:Copper; D006590:Hexetidine